Title : Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.

Pub. Date : 2003 Mar 24

PMID : 12644821






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BCL-2 and BAX, but not MEK1 expressions have predictive value in ovarian cancer patients treated with platinum-based chemotherapy. Platinum BCL2 apoptosis regulator Homo sapiens